STOCK TITAN

Indivior PLC (INDV) CFO discloses initial Form 3 share stakes holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Indivior PLC’s chief financial officer Ryan Preblick has filed an initial Form 3 disclosing his equity holdings in the company. He beneficially owns 280,582 ordinary shares directly. In addition, he holds restricted stock units that each represent a contingent right to receive one ordinary share of Indivior PLC.

One grant covers 6,302 restricted stock units that were awarded on March 14, 2024 and vest in a single installment on March 14, 2026. A second grant covers 70,459 restricted stock units that were awarded on March 7, 2025 and vest in a single installment on March 7, 2028. All positions are reported as directly owned, and the filing also includes a power of attorney authorizing the signatory to sign on his behalf.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Preblick Ryan

(Last) (First) (Middle)
10710 MIDLOTHIAN TURNPIKE
SUITE 125

(Street)
NORTH CHESTERFIELD VA 23235

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026
3. Issuer Name and Ticker or Trading Symbol
INDIVIOR PLC [ INDV ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 280,582 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units 03/14/2026(1) (1) Ordinary Shares 6,302 $0 D
Restricted Stock Units 03/07/2028(2) (2) Ordinary Shares 70,459 $0 D
Explanation of Responses:
1. Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of Indivior PLC. These RSUs were granted on March 14, 2024 and vest in a single installment on March 14, 2026.
2. Each RSU represents a contingent right to receive one ordinary share of Indivior PLC. These RSUs were granted on March 7, 2025 and vest in a single installment on March 7, 2028.
Remarks:
Exhibit 24 Power of Attorney
/s/Jordan Saltzberg, Power of Attorney 01/07/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Indivior

NASDAQ:INDV

INDV Rankings

INDV Latest News

INDV Latest SEC Filings

INDV Stock Data

4.19B
120.21M
3.88%
88.1%
6.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SLOUGH, BERKSHIRE